EN  |  JP

CMIC is your trusted service partner for the U.S., Japan and Asia.

With our extensive range of services, bredth and depth of expertise, and proven track record as the first Contract Research Oranization (CRO) in Japan, CMIC Group is your strategic partner for your entire drug development process.

Orphan Drug Development in Japan

How can we accelerate rare disease patients’ access to therapies?

Supporting nearly 80% of new drug development in Japan

With over 25 years of CRO expertise in Japan, as well as other services for drug development and commercialization, CMIC makes your success our focus.

Pharmaceutical Value Creator

Our PVC business model supports an entire value chain for pharmaceutical companies, including drug development, manufacturing, sales and marketing.

CMIC is your trusted service partner for the U.S., Japan and Asia.

With our extensive range of services, bredth and depth of expertise, and proven track record as the first Contract Research Oranization (CRO) in Japan, CMIC Group is your strategic partner for your entire drug development process.

Orphan Drug Development in Japan

How can we accelerate rare disease patients’ access to therapies?

Supporting nearly 80% of new drug development in Japan

With over 25 years of CRO expertise in Japan, as well as other services for drug development and commercialization, CMIC makes your success our focus.

Pharmaceutical Value Creator

Our PVC business model supports an entire value chain for pharmaceutical companies, including drug development, manufacturing, sales and marketing.

Our Services

CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward.

View our services below by selecting the phase of drug development that you are working in:

Pre-Clinical

Clinical
Phase I-III

Approval

Post-Approval

Sales &
Marketing

Pre-Clinical

Clinical
Phase I-III

Approval

Post-Approval

Sales &
Marketing

Our Tailored Solutions

CMIC offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications.

Japanese Market Entry

Providing full pharmaceutical capabilities for overseas business partners to enter into Japan market.
Learn More

Asia Clinical Trials

Supporting our client’s clinical trials throughout the Asia Pacific region. Providing solutions for a range of therapeutic areas, registry study, observational study, phases II/III clinical trials, phase IV clinical trials, post-marketing surveillance.
Learn More

Medical Device & IVD

Consultation services on regulatory issues for the latest medical devices and in vitro diagnostics (IVD).
Learn More

Oncology Drug Development

Specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology.
Learn More

Regenerative Medicine

Established systems ready to implement and form development strategies and support every stage of the regenerative medicine lifecycle, including regulatory consulting, various nonclinical and clinical studies, and post-marketing.
Learn More

Orphan Drug

OrphanPacific is a pharmaceutical company within CMIC Group, which provides wealth of experience in the field of orphan drugs: regulatory affairs, supply chain management, quality management and marketing strategy planning.
Learn More

Latest Resources

Clinical Trials in Japan

White Papers

[White Paper] How To Run Successful Clinical Trials In Japan

Download

eBook

[eBook] Clinical Trials in Asia

Download

eBook

[eBook] Pharmaceutical Development and Manufacturing: Challenges and Opportunities

Download

Webinars

[Webinar] Tips to Ensure Market Entry Success in Japan: Challenges, Regulatory Updates and Success Factors

Watch Now

Webinars

[Webinar] Critical Insights for Oncology Drug Development in Japan and Asia

Watch Now

Webinars

[Webinar] Advanced ODT Technologies for Drug Development in Japan and the US

Watch Now

White Papers

[White Paper/Infographic] The Changing Face of Global Clinical Trials: Asia-Pacific as an Ideal Destination for Specialty Biopharma

Download

Webinars

[Webinar] Overcoming Challenges of Bioanalytical Method Development for Oligonucleotides and Large Molecules

Watch Now

Scientific Publications

[Journal Article] Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team

Download

Scientific Posters

[Poster] Analytical Method for the Determination of Capecitabine and Its Metabolites in Human Plasma

Download

Brochures

CMIC Group Corporate Brochure

Download

Brochures

Drug Development and Manufacturing Brochure

Download

Brochures

Regenerative Medicine Brochure

Download

Webinars

[Webinar] Regenerative Medicine Development in Japan: Challenges and Key Success Factors for Rapid Approval

Watch Now